Economic and Clinical Impact of Stroke and Warfarin Use for Patients with Non-valvular Atrial Fibrillation
**Background:** Atrial fibrillation (AF) is a common clinical problem and potent risk factor for stroke. However, real-world effectiveness and outcomes for AF patients are not well described. **Objective:** To compare the economic and clinical impact of stroke and warfarin use on patients with nonv...
Saved in:
Main Authors: | Li Wang, Elyse Fritschel, Onur Baser |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2013-11-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9852 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain
by: Carlos Rubio-Terrés, et al.
Published: (2016-02-01) -
Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria
by: Yazid Aoudia, et al.
Published: (2017-05-01) -
Detecting Atrial Fibrillation Using Smartwatches
by: Agnieszka Kulczycka-Rowicka, et al.
Published: (2025-02-01) -
Applied Comparison of Meta-analysis Techniques
by: Li Wang, et al.
Published: (2013-02-01) -
Global trends and epidemiological impact of metabolic risk factors on atrial fibrillation and atrial flutter from 1990 to 2021
by: Junqing Liang, et al.
Published: (2025-02-01)